Næste

Automatisk afspilning

Progression of Metastatic Pancreatic Cancer

6 Visninger • 07/30/23
Del
Indlejre
administrator
administrator
Abonnenter
0

George Kim, MD, discusses treatment options for second-line therapy in patients with gemcitabine-refractory pancreatic cancer based on the NCCN guidelines.

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/

Vis mere
0 Kommentarer sort Sorter efter
Facebook kommentarer

Næste

Automatisk afspilning